Cargando…

Dasatinib-induced Pulmonary Hypertension

Detalles Bibliográficos
Autores principales:	Tamura, Yudai, Tamura, Yuichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424095/ https://www.ncbi.nlm.nih.gov/pubmed/35110497 http://dx.doi.org/10.2169/internalmedicine.9107-21

Ejemplares similares

Current clinical understanding and effectiveness of portopulmonary hypertension treatment
por: Tamura, Yuichi, et al.
Publicado: (2023)

Case report: Pathological differences in pulmonary arterial hypertension in long-term responders to calcium channel blockers
por: Tamura, Yuichi, et al.
Publicado: (2023)

Relationship between Dasatinib-induced Pulmonary Hypertension and Drug Dose
por: Kubota, Kana, et al.
Publicado: (2022)

Usefulness of Longitudinal Strain to Assess Cancer Therapy-Related Cardiac Dysfunction and Immune Checkpoint Inhibitor-Induced Myocarditis
por: Tamura, Yudai, et al.
Publicado: (2023)

Long‐term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertension
por: Tamura, Yuichi, et al.
Publicado: (2022)

Dasatinib-Induced Pulmonary Arterial Hypertension Treated with Upfront Combination Therapy
por: Nishimori, Makoto, et al.
Publicado: (2018)

Pulmonary hypertension with dasatinib and other tyrosine kinase inhibitors
por: El-Dabh, Ashraf, et al.
Publicado: (2019)

Combination targeted pulmonary hypertension therapy in the resolution of Dasatinib-associated pulmonary arterial hypertension
por: Jose, Arun, et al.
Publicado: (2017)

Rho-Kinase Inhibition Ameliorates Dasatinib-Induced Endothelial Dysfunction and Pulmonary Hypertension
por: Fazakas, Csilla, et al.
Publicado: (2018)

Dasatinib-induced pulmonary arterial hypertension complicated with scleroderma: a case report
por: Toya, Takumi, et al.
Publicado: (2019)

Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia
por: Hong, Ji Hyung, et al.
Publicado: (2015)

A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities
por: Nekoukar, Zahra, et al.
Publicado: (2021)

Pulmonary arterial hypertension in a patient treated with dasatinib: a case report
por: Skride, Andris, et al.
Publicado: (2017)

Melatonin Attenuates Dasatinib-Aggravated Hypoxic Pulmonary Hypertension via Inhibiting Pulmonary Vascular Remodeling
por: Wang, Rui, et al.
Publicado: (2022)

A Dasatinib-Induced Chylothorax Persisting After the Discontinuation of Dasatinib
por: Bradt, Nicolas, et al.
Publicado: (2022)

Expanding dasatinib beyond KIT in acute myeloid leukemia
por: Welch, John S.
Publicado: (2020)

Variables associated with pulmonary hypertension screened by echocardiography in chronic myeloid leukemia patients on dasatinib therapy
por: Jin, Wenying, et al.
Publicado: (2022)

Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?
por: Hennigs, Jan K, et al.
Publicado: (2011)

Change of right ventricular systolic pressure can indicate dasatinib‐induced pulmonary arterial hypertension in chronic myeloid leukemia
por: Lee, Sung‐Eun, et al.
Publicado: (2021)

A case of worsening pulmonary arterial hypertension and pleural effusions by bosutinib after prior treatment with dasatinib
por: Seegobin, Karan, et al.
Publicado: (2017)

Dasatinib-induced Nonspecific Interstitial Pneumonia That Developed 7 Years after the Initiation of Dasatinib
por: Takekoshi, Daisuke, et al.
Publicado: (2020)

Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with Pulmonary Arterial Hypertension (EPITOME4)
por: Tamura, Yuichi, et al.
Publicado: (2013)

Platypnoea–orthodeoxia syndrome induced by short-term weight loss: a case series
por: Tamura, Yudai, et al.
Publicado: (2020)

Usefulness of Global Longitudinal Strain-Guided Management in Preventing Human Epidermal Growth Factor Receptor 2 (HER2) Inhibitor-Induced Myocardial Damage
por: Yamada, Kenta, et al.
Publicado: (2022)

How do the 2022 European Society of Cardiology/European Respiratory Society guidelines modify the diagnosis of portopulmonary hypertension in patients with cirrhosis complicated by portal hypertension? A post hoc analysis
por: Atsukawa, Masanori, et al.
Publicado: (2023)

Pulmonary hypertension associated with neurofibromatosis type 2
por: Taniguchi, Hirohisa, et al.
Publicado: (2021)

Pulmonary Artery Pressure as a Treatment Target to Improve the Prognosis of Idiopathic Pulmonary Arterial Hypertension　― Insight From a Cohort From Two Japanese Pulmonary Hypertension Centers ―
por: Ishiguro, Midori, et al.
Publicado: (2020)

SATISFY‐JP, a phase II multicenter open‐label study on Satralizumab, an anti‐IL‐6 receptor antibody, use for the treatment of pulmonary arterial hypertension in patients with an immune‐responsive‐phenotype: Study protocol
por: Tamura, Yuichi, et al.
Publicado: (2023)

Dasatinib-Induced Bilateral Pleural Effusions
por: Rasul, Taha F, et al.
Publicado: (2022)

Reversible ventricular arrythmia induced by dasatinib
por: Spechbach, Hervé, et al.
Publicado: (2013)

Dasatinib induced pleural effusions - Reply
por: AJ Abdulla, Mohammad, et al.
Publicado: (2020)

Dasatinib induced pleuro-pericardial effusion
por: Mishra, Ajay Kumar, et al.
Publicado: (2020)

Dasatinib-Induced Pleural and Pericardial Effusions
por: Hailan, Yousef M, et al.
Publicado: (2021)

Successful treatment with nilotinib after bosutinib-induced pulmonary arterial hypertension recurrence following dasatinib in chronic myeloid leukemia in chronic phase
por: Takatsuka, Ibuki, et al.
Publicado: (2022)

Successful transition from Treprostinil to Selexipag in patient with severe pulmonary arterial hypertension
por: Furukawa, Asuka, et al.
Publicado: (2017)

Erratum to: Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with a Pulmonary Arterial Hypertension (EPITOME4)
por: Tamura, Yuichi, et al.
Publicado: (2013)

Pulmonary Hypertension
por: Basyigit, Ilknur, et al.
Publicado: (2012)

Dasatinib-induced reversible pulmonary arterial hypertension in a pediatric patient with BCR/ABL1+ lymphoblastic lymphoma from chronic myeloid leukemia
por: Han, Hye-ji, et al.
Publicado: (2022)

Balloon Pulmonary Angioplasty for Recurrent Lesions Six Years Following Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension
por: Tamura, Hiroto, et al.
Publicado: (2023)

Dasatinib-Related Chylothorax
por: Huang, Yen-Min, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bojsrucvu4ja7jerenpk9n2sqj